Table 2.
Demographics and health characteristics of participants enrolled in Vida Plena (N=21).
| Demographics | Survivor (n=14) | Caregiver (n=7) | Total | ||||
| Age (years), mean (SD) | 57.4 (12.4) | 41.1 (15.3) | 52.0 (15.2) | ||||
| Sex (female), n (%) | 14 (100) | 5 (71) | 19 (90) | ||||
| Education, n (%) | |||||||
|
|
High school or less | 7 (50) | 4 (57) | 11 (19) | |||
|
|
Bachelor’s degree or higher | 7 (50) | 3 (43) | 10 (38) | |||
| Hispanic populationa, n (%) | 13 (100) | 7 (100) | 20 (100) | ||||
| Mexican origin, n (%) | 14 (100) | 7 (100) | 21 (100) | ||||
| Lived in current neighborhood (years), n (%) | |||||||
|
|
<10 | 5 (36) | 4 (57) | 9 (43) | |||
|
|
≥10 | 9 (64) | 3 (43) | 12 (57) | |||
| Spanish primary language spoken, n (%) | 14 (100) | 5 (71) | 19 (90) | ||||
| Currently married, n (%) | 8 (57) | 4 (57) | 12 (57) | ||||
| Employment, n (%) | |||||||
|
|
None | 12 (86) | 3 (43) | 15 (71) | |||
|
|
Part time or full time | 2 (14) | 4 (37) | 4 (19) | |||
| Cancer diagnosis, n (%) | |||||||
|
|
Breast | 14 (100) | N/Ab | N/A | |||
| Cancer stage at diagnosis, n (%) | |||||||
|
|
Stage 1 | 3 (21) | N/A | N/A | |||
|
|
Stage 2 | 5 (36) | N/A | N/A | |||
|
|
Stage 3 | 3 (21) | N/A | N/A | |||
|
|
Not known | 3 (21) | N/A | N/A | |||
| Age diagnosed (years), mean (SD) | 49.6 (12.4) | N/A | N/A | ||||
| In active treatment, n (%) | 7 (50) | N/A | N/A | ||||
| Family history of cancer, n (%) | 10 (71) | 5 (71) | 15 (71) | ||||
| BMI (kg/m2), mean (SD) | 28.8 (6.2) | 29.7 (5.7) | 29.1 (5.9) | ||||
| Ever smoked, n (%) | 3 (21) | 3 (43) | 6 (29) | ||||
| Any comorbid condition, n (%) | 14 (100) | N/A | N/A | ||||
| Count of comorbid conditionsc, n (%) | |||||||
|
|
None | 0 (0) | N/A | N/A | |||
|
|
1-3 | 6 (43) | N/A | N/A | |||
|
|
≥4 | 8 (57) | N/A | N/A | |||
aMissing data n=1.
bN/A: not applicable.
cComorbidities include type 2 diabetes, asthma, depression or anxiety, heart disease, vision problems, arthritis, chronic gastrointestinal conditions, sleep disorder, high cholesterol, pain, and other comorbid conditions. Comorbidity data were not collected for cancer caregivers.